Office Management of Chronic Systolic Heart Failure
Abstract
Evidence-based management of chronic systolic heart failure includes risk factor management, therapeutic lifestyle changes, and a polypharmaceutical regimen that prolongs survival, reduces or reverses progression of myocardial dysfunction, alleviates symptoms, and limits complications. Subspecialty consultation is warranted when symptoms progress despite standard therapy; interventions are needed for refractory coronary disease, an arrhythmia device is indicated, or surgical intervention or transplantation is considered.
Keywords: Chronic disease, Drug therapy, Heart failure, Medical management, Systolic
To access this article, please choose from the options below
Funding: None.
Conflict of Interest: None of the authors has any potential conflict of interest regarding the publication of this manuscript.
Authorship: All authors had access to the data and a role in writing this manuscript.
PII: S0002-9343(09)00007-2
doi:10.1016/j.amjmed.2008.12.011
Published by Elsevier Inc.

